We are live on ! Find out more
DCOY

Decoy Therapeutics
DCOY

7 hedge funds and large institutions have $51.4K invested in Decoy Therapeutics in 2025 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

2,459% more capital invested

Capital invested by funds: $2.01K → $51.4K (+$49.4K)

200% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 2

133% more funds holding

Funds holding: 3 → 7 (+4)

0.1% more ownership

Funds ownership: 0.01% → 0.11% (+0.1%)

Holders
7
Holders Change
+4
Holders Change %
+133.33%
% of All Funds
0.08%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
1
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
WAM
Warberg Asset Management
Illinois
+$60.5K
2
SG
StoneX Group
New York
+$43.2K
3
XT
XTX Topco
Cayman Islands
+$23.6K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$23.6K
5
UBS Group
UBS Group
Switzerland
+$10.6K

Top Sellers

Rank Fund Capital Flow
1
ASN
Advisory Services Network
Georgia
-$1.83K
2
Osaic Holdings
Osaic Holdings
Arizona
-$130

DCOY Hedge Fund Activity: Q4 2025 in Review

7 of the 8,266 institutional investors tracked by Wall St. Rank reported a position in Decoy Therapeutics (DCOY) for Q4 2025, worth a combined $51.4K — up 2,459% from $2.01K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new DCOY positions and 2 closed out — a net gain of 4 holders — while 1 added to existing stakes and 0 trimmed.

The largest buyer was Warberg Asset Management, opening a new position worth an estimated $60.5K. The largest seller was Advisory Services Network, exiting entirely with an estimated $1.83K sold.

  • 7 institutional investors held Decoy Therapeutics (DCOY) as of Q4 2025, up from 3 in Q3 2025.
  • Funds reported $51.4K of Decoy Therapeutics stock for Q4 2025, up 2,459% quarter-over-quarter.
  • 6 funds opened new Decoy Therapeutics positions in Q4 2025 and 2 closed out, a net change of +4 holders.
  • The largest Decoy Therapeutics buyer in Q4 2025 was Warberg Asset Management, an estimated $60.5K added.
  • The largest Decoy Therapeutics seller in Q4 2025 was Advisory Services Network, an estimated $1.83K sold.

Based on aggregated 13F filings for Q4 2025.